Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations. 5. Lipolysis of Representative Formulations by Gastric Lipase

PurposeLipid-based formulations (LBF) are substrates for digestive lipases and digestion can significantly alter their properties and potential to support drug absorption. LBFs have been widely examined for their behaviour in the presence of pancreatic enzymes. Here, the impact of gastric lipase on the digestion of representative formulations from the Lipid Formulation Classification System has been investigated.MethodsThe pHstat technique was used to measure the lipolysis by recombinant dog gastric lipase (rDGL) of eight LBFs containing either medium (MC) or long (LC) chain triglycerides and a range of surfactants, at various pH values [1.5 to 7] representative of gastric and small intestine contents under both fasting and fed conditions.ResultsAll LBFs were hydrolyzed by rDGL. The highest specific activities were measured at pH 4 with the type II and IIIA MC formulations that contained Tween®85 or Cremophor EL respectively. The maximum activity on LC formulations was recorded at pH 5 for the type IIIA-LC formulation. Direct measurement of LBF lipolysis using the pHstat, however, was limited by poor LC fatty acid ionization at low pH.ConclusionsSince gastric lipase initiates lipid digestion in the stomach, remains active in the intestine and acts on all representative LBFs, its implementation in future standardized in vitro assays may be beneficial. At this stage, however, routine use remains technically challenging.

[1]  Li Di,et al.  Drug-like property concepts in pharmaceutical design. , 2009, Current pharmaceutical design.

[2]  P. Hadváry,et al.  Inhibition of gastrointestinal lipolysis by Orlistat during digestion of test meals in healthy volunteers. , 2001, American journal of physiology. Gastrointestinal and liver physiology.

[3]  E. Meugnier,et al.  Coupling in vitro gastrointestinal lipolysis and Caco-2 cell cultures for testing the absorption of different food emulsions. , 2012, Food & function.

[4]  R. Verger,et al.  Purification and biochemical characterization of dog gastric lipase. , 1991, European journal of biochemistry.

[5]  P. Artursson,et al.  Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. , 1998, The Journal of pharmacology and experimental therapeutics.

[6]  F. Carrière,et al.  Comparative study on digestive lipase activities on the self emulsifying excipient Labrasol, medium chain glycerides and PEG esters. , 2007, Biochimica et biophysica acta.

[7]  M. Egret‐Charlier,et al.  Ionization of fatty acids at the lipid—water interface , 1978, FEBS letters.

[8]  P. Berna,et al.  Crystal Structure of the Open Form of Dog Gastric Lipase in Complex with a Phosphonate Inhibitor* , 2002, The Journal of Biological Chemistry.

[9]  R. Verger,et al.  Inactivation of pancreatic and gastric lipases by THL and C12:0-TNB: a kinetic study with emulsified tributyrin. , 1991, Biochimica et biophysica acta.

[10]  Jean-Michel Kauffmann,et al.  The effects of excipients on transporter mediated absorption. , 2010, International journal of pharmaceutics.

[11]  F. Carrière,et al.  In Vitro Gastrointestinal Lipolysis of Four Formulations of Piroxicam and Cinnarizine with the Self Emulsifying Excipients Labrasol® and Gelucire® 44/14 , 2009, Pharmaceutical Research.

[12]  A. Müllertz,et al.  Toward the Establishment of Standardized In Vitro Tests for Lipid-Based Formulations, Part 3: Understanding Supersaturation Versus Precipitation Potential During the In Vitro Digestion of Type I, II, IIIA, IIIB and IV Lipid-Based Formulations , 2013, Pharmaceutical Research.

[13]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 1: method parameterization and comparison of in vitro digestion profiles across a range of representative formulations. , 2012, Journal of pharmaceutical sciences.

[14]  D. Hauss.  Oral lipid-based formulations. , 2007, Advanced drug delivery reviews.

[15]  F. Carrière,et al.  Understanding the lipid-digestion processes in the GI tract before designing lipid-based drug-delivery systems. , 2012, Therapeutic delivery.

[16]  C. Pouton,et al.  Enhancing intestinal drug solubilisation using lipid-based delivery systems. , 2008, Advanced drug delivery reviews.

[17]  R. Verger,et al.  The specific activities of human digestive lipases measured from the in vivo and in vitro lipolysis of test meals. , 2000, Gastroenterology.

[18]  L. Sarda,et al.  Kinetic assay of human gastric lipase on short- and long-chain triacylglycerol emulsions. , 1986, Gastroenterology.

[19]  Gordon L Amidon,et al.  A Mechanistic Approach to Understanding the Factors Affecting Drug Absorption: A Review of Fundamentals , 2002, Journal of clinical pharmacology.

[20]  P. Desnuelle,et al.  Action of some effectors on the hydrolysis of long-chain triglycerides by pancreatic lipase. , 1968, Biochimica et biophysica acta.

[21]  C. Pouton,et al.  Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  Christopher J H Porter,et al.  Lipid-based systems for the enhanced delivery of poorly water soluble drugs. , 2008, Advanced drug delivery reviews.

[23]  P. Constantinides,et al.  Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies. , 2007, Journal of pharmaceutical sciences.

[24]  L. Sarda,et al.  Importance of human gastric lipase for intestinal lipolysis: an in vitro study. , 1986, Biochimica et biophysica acta.

[25]  G. Benzonana.  Sur le role des ions calcium durant l'hydrolyse des triglycerides insolubles par la lipase pancreatique en presence de sels biliares , 1968 .

[26]  R. Verger,et al.  Physiology of Gastrointestinal Lipolysis and Therapeutical Use of Lipases and Digestive Lipase Inhibitors , 2005 .

[27]  R. Verger,et al.  Crystal Structure of Human Gastric Lipase and Model of Lysosomal Acid Lipase, Two Lipolytic Enzymes of Medical Interest* , 1999, The Journal of Biological Chemistry.

[28]  D. Cistola,et al.  The Ionization Behavior of Fatty Acids and Bile Acids in Micelles and Membranes , 1984, Hepatology.

[29]  F. Carrière,et al.  In Vitro Digestion of the Self-Emulsifying Lipid Excipient Labrasol® by Gastrointestinal Lipases and Influence of its Colloidal Structure on Lipolysis Rate , 2013, Pharmaceutical Research.

[30]  Li Di,et al.  Bridging solubility between drug discovery and development. , 2012, Drug discovery today.

[31]  R. Laugier,et al.  Quantitative study of digestive enzyme secretion and gastrointestinal lipolysis in chronic pancreatitis. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[32]  Jean-David Rodier,et al.  Lipolysis of the semi-solid self-emulsifying excipient Gelucire 44/14 by digestive lipases. , 2008, Biochimica et biophysica acta.

[33]  Christopher J H Porter,et al.  AN EXAMINATION OF THE INTERPLAY BETWEEN ENTEROCYTE-BASED METABOLISM AND LYMPHATIC DRUG TRANSPORT IN THE RAT , 2006, Drug Metabolism and Disposition.

[34]  C. Porter,et al.  Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs , 2007, Nature Reviews Drug Discovery.

[35]  D. Brocks,et al.  The effect of oral lipids and circulating lipoproteins on the metabolism of drugs , 2009, Expert opinion on drug metabolism & toxicology.

[36]  M. Devignes,et al.  The complete cDNA sequence encoding dog gastric lipase. , 1998, DNA sequence : the journal of DNA sequencing and mapping.

[37]  F. Carrière,et al.  In vitro digestion of citric acid esters of mono- and diglycerides (CITREM) and CITREM-containing infant formula/emulsions. , 2014, Food & function.

[38]  P. Constantinides,et al.  Lipid Microemulsions for Improving Drug Dissolution and Oral Absorption: Physical and Biopharmaceutical Aspects , 1995, Pharmaceutical Research.

[39]  R. Verger,et al.  In vivo and in vitro studies on the stereoselective hydrolysis of tri- and diglycerides by gastric and pancreatic lipases. , 1997, Bioorganic & medicinal chemistry.

[40]  Hywel D Williams,et al.  Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.

[41]  R. Verger,et al.  Gastric and pancreatic lipase levels during a test meal in dogs. , 1993, Scandinavian journal of gastroenterology.

[42]  R. Verger,et al.  Secretion and contribution to lipolysis of gastric and pancreatic lipases during a test meal in humans. , 1993, Gastroenterology.

[43]  A. Müllertz,et al.  Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion. , 2012, Molecular pharmaceutics.

[44]  F. Carrière,et al.  In Vitro Gastrointestinal Lipolysis: Replacement of Human Digestive Lipases by a Combination of Rabbit Gastric and Porcine Pancreatic Extracts , 2011 .